v3.26.3
SHARE-BASED COMPENSATION AND WARRANTS (Tables)
12 Months Ended
Jun. 30, 2026
SHARE-BASED COMPENSATION AND WARRANTS  
Schedule of the number of shares authorized, outstanding, and available for future grants under stock option

Presented below is a summary of the number of shares authorized, outstanding, and available for future grants under the Company’s equity incentive plans as of June 30, 2026:

​

​

​

​

​

​

​

​

  ​ ​ ​

Number of Shares

Description

  ​ ​ ​

Authorized

  ​ ​ ​

Outstanding

  ​ ​ ​

Available

2015 Plan

 

14,000

​

14,000

 

—

2016 Plan

 

115,200

​

115,200

 

—

2019 Plan

 

200,000

 

200,000

 

—

2021 Plan

​

20,193,552

​

13,664,566

​

6,528,986

Inducement Awards

​

1,500,000

​

705,000

​

795,000

Total

 

22,022,752

 

14,698,766

(1)

7,323,986

(1)Consists of approximately 12.5 million shares outstanding under stock option agreements and 2.2 million shares under restricted stock units.
Schedule of the stock option plans

The following table summarizes the combined stock option activity under the Company’s equity incentive plans and inducement awards, for the fiscal years ended June 30, 2026 and 2025:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

2026

​

2025

​

  ​ ​ ​

Shares

  ​ ​ ​

Price (1)

  ​ ​ ​

Term (2)

​

Shares

  ​ ​ ​

Price (1)

  ​ ​ ​

Term (2)

Outstanding, beginning of fiscal year

 

13,027,994

​

$

4.03

 

7.7

​

10,890,540

​

$

3.82

​

8.1

Granted

​

2,506,000

​

​

8.64

​

​

​

3,246,300

​

​

4.57

​

​

Exercised

​

(825,953)

(3)

​

2.18

​

​

​

(488,742)

(3)

​

2.85

​

​

Expired

​

(346,745)

​

​

4.86

​

​

​

(69,666)

​

​

12.17

​

​

Forfeited

​

(1,892,865)

​

​

6.22

​

​

​

(550,438)

​

​

3.08

​

​

Outstanding, end of fiscal year

 

12,468,431

(4)

 

4.73

 

6.9

​

13,027,994

(4)

 

4.03

 

7.7

Vested, end of fiscal year

 

9,145,633

(5)

 

4.37

 

6.2

​

7,127,835

(5)

 

4.48

 

6.9

(1)Represents the weighted average exercise price.
(2)Represents the weighted average remaining contractual term until the stock options expire.
(3)The total intrinsic value (the amount by which the fair market value exceeded the exercise price) of stock options exercised during the year ended June 30, 2026 and 2025, was $2.5 million and $0.9 million, respectively.
(4)As of June 30, 2026 and 2025, the intrinsic value of outstanding stock options was approximately $19.4 million and $14.9 million, respectively.
(5)As of June 30, 2026 and 2025, the aggregate intrinsic value of vested stock options was approximately $16.1 million and $8.5 million, respectively.
Schedule of the fair value of stock options

The fair value of stock options was estimated on the dates of grant using the BSM option-pricing model, with the following weighted-average assumptions for the fiscal years ended June 30, 2026 and 2025:

​

​

​

​

​

​

​

​

​

  ​ ​ ​

2026

​

2025

Market price of common stock on grant date

​

$

8.64

​

$

4.57

​

Expected volatility

  ​ ​ ​

​

84

%

​

84

%

Risk free interest rate

 

​

3.8

%

​

4.2

%

Expected term (years)

 

​

5.9

​

​

5.9

​

Dividend yield

 

​

0

%

​

0

%

Schedule of the combined RSU activity

The following table summarizes the RSU activity under the Company’s 2021 Plan, for the fiscal years ended June 30, 2026 and 2025:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

2026

​

2025

​

  ​ ​ ​

Shares

  ​ ​ ​

Price (1)

​

Shares

  ​ ​ ​

Price (1)

Unvested, beginning of fiscal year

 

1,056,500

​

$

4.55

​

—

​

$

—

Granted

​

1,915,000

​

​

10.11

​

1,056,500

​

​

4.55

Vested

​

(360,165)

(2)

​

4.61

​

—

​

​

—

Forfeited

​

(381,000)

​

​

9.56

​

—

​

​

—

Unvested, end of fiscal year

 

2,230,335

​

 

8.46

​

1,056,500

​

 

4.55

(1)Represents the weighted average fair value per share based on the closing market price of the Company’s common stock on the grant date of the respective RSUs.
(2)Based on the closing market price of the Company’s common stock on the respective vesting dates, the aggregate fair value for the RSUs that vested during the fiscal year ended June 30, 2026, amount to $1.2 million or approximately $3.24 per share.
Schedule of share-based compensation expense

Share-based compensation expense is included under the following captions in the consolidated statements of operations for the fiscal years ended June 30, 2026 and 2025 (in thousands):

​

​

​

​

​

​

​

​

​

2026

  ​ ​ ​

2025

Research and development

​

$

6,473

​

$

3,502

General and administrative

​

 

7,987

​

 

3,619

Total

​

$

14,460

​

$

7,121

Legacy warrants  
SHARE-BASED COMPENSATION AND WARRANTS  
Schedule of warrant activity The following table summarizes the activity related to the Legacy Warrants for the fiscal years ended June 30, 2026 and 2025:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

2026

​

2025

​

  ​ ​

Shares

  ​ ​

Price (1)

  ​ ​

Term (2)

  ​ ​

Shares

  ​ ​

Price (1)

  ​ ​

Term (2)

Outstanding, beginning of fiscal year

 

850,442

  ​

$

19.90

 

2.3

 

860,562

  ​

$

20.28

 

3.2

Expirations

 

(660)

  ​

​

67.55

 

​

 

(10,120)

  ​

​

52.20

 

​

Outstanding, end of fiscal year

 

849,782

  ​

 

19.86

 

1.3

 

850,442

  ​

 

19.90

 

2.3

(1)Represents the weighted average exercise price.
(2)Represents the weighted average remaining contractual term for the number of years until the warrants expire.